Clinical trial · Interventional
Spectrum Analysis in Ex-vivo Human Lungs
Spectrum Analysis of Endobronchial Ultrasound Radiofrequency of Lung Tumors in Ex-vivo Human Lungs
NCT03356743CI-TRIAL-00032789completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will analyze spectral features of the radiofrequency of lung tumors in ex-vivo human lungs. The resected specimens will be evaluated using the spectrum analysis to determine the localization rate of the targets. Ultrasound measurement and images will be used for correlation of TS mode image findings with pathology by using HE and IHC slides of lung tumor and lymph node.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Spectrum Analysis | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Ex-Vivo
- interventionNames
- Device: Spectrum Analysis
Primary outcomes (1)
- measure
- To analyze the relationship of three spectral features of the radiofrequency of lung tumors in ex-vivo human lungs.
- timeFrame
- Within an hour after resection.
- description
- From obtained ultrasound images, a linear regression line is quantified, and three ultrasonic spectral parameters including Midband-fit, Intercept, and Slope are calculated.
Secondary outcomes (2)
- measure
- To find the correlation of TS mode image findings with pathology by using lung tumor and lymph node samples.
- timeFrame
- Within an hour after resection
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any patients scheduled for lobectomy of anatomical segmental resection for malignant lung tumors. * 18 years of age or older Exclusion Criteria: * Any patients with inability to give informed consent.
References
Publications (0)
Data not yet available
No reference posted for this study.